Sarah K Laing
Biographic Data
| ID | 6330617 |
|---|---|
| NAME | Sarah K Laing |
| GIVEN NAMES | Sarah K |
| FAMILY NAME | Laing |
| SIGNATURE | LAING S K |
| AFFILIATIONS | University of North Carolina at Chapel Hill |
| VERIFIED | No |
| TOTAL WORKS | 3 |
| TOTAL CITATIONS | 1 |
| AUTHOR COUNT | 3 |
| EDITOR COUNT | 0 |
| FIRST PUBLICATION YEAR | 2019 |
| LATEST PUBLICATION YEAR | 2022 |
| H-INDEX | 1 |
Educational and economic returns to cognitive ability in low- and middle-income countries
Impact of substandard and falsified antimalarials in Zambia
Eliminating substandard and falsified antimalarials is an important step towards a malaria-free Zambia. Beyond the dissemination of insecticide-treated bed nets, indoor residual spraying, and other malaria control measures, attention must also be paid to assure the quality of antimalarial treatments
Poor-quality antimalarials further health inequities in Uganda
Substandard and falsified medications are a major threat to public health, directly increasing the risk of treatment failure, antimicrobial resistance, morbidity, mortality and health expenditures. While antimalarial medicines are one of the most common to be of poor quality in low- and middle-income countries, their distributional impact has not been examined. This study assessed the health equity impact of substandard and falsified antimalarial…
Poor-quality antimalarials further health inequities in Uganda
Substandard and falsified medications are a major threat to public health, directly increasing the risk of treatment failure, antimicrobial resistance, morbidity, mortality and health expenditures. While antimalarial medicines are one of the most common to be of poor quality in low- and middle-income countries, their distributional impact has not been examined. This study assessed the health equity impact of substandard and falsified antimalarial…
Poor-quality antimalarials further health inequities in Uganda
Substandard and falsified medications are a major threat to public health, directly increasing the risk of treatment failure, antimicrobial resistance, morbidity, mortality and health expenditures. While antimalarial medicines are one of the most common to be of poor quality in low- and middle-income countries, their distributional impact has not been examined. This study assessed the health equity impact of substandard and falsified antimalarial…
Impact of substandard and falsified antimalarials in Zambia
Eliminating substandard and falsified antimalarials is an important step towards a malaria-free Zambia. Beyond the dissemination of insecticide-treated bed nets, indoor residual spraying, and other malaria control measures, attention must also be paid to assure the quality of antimalarial treatments
Educational and economic returns to cognitive ability in low- and middle-income countries
Environmental health (2 works) · Malaria (2 works) · Medicine (2 works) · Pharmaceutical Economics and Policy (2 works) · Pharmaceutical Quality and Counterfeiting (2 works) · Psychological intervention (2 works) · Public health (2 works) · Artemisinin (1 work) · Biostatistics (1 work) · Business (1 work)